An L-type calcium channel blocker
Related Products
Active Metabolite(s)
23229Dehydro Nifedipine
Labeled Version(s)
25510Nifedipine-d6
Metabolite(s)
34406Hydroxydehydro Nifedipine Carboxylate
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Nifedipine

Item No. 11106

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylic acid, 3,5-dimethyl ester
CAS Number
21829-25-4
Synonyms
  • BAY 1040
Molecular Formula
C17H18N2O6
Formula Weight
346.3
Purity
≥98%
Formulation
A crystalline solid
Solubility(Learn about Variance in Solubility)
DMF: 30 mg/mlDMSO: 30 mg/mlDMSO:PBS (pH 7.2) (1:10): 0.1 mg/mlEthanol: 1 mg/ml
λmax
236, 334, 360 nm
SMILES
CC1=C(C(OC)=O)C(C(C(OC)=O)=C(C)N1)C2=CC=CC=C2[N+]([O-])=O
InChi Code
InChI=1S/C17H18N2O6/c1-9-13(16(20)24-3)15(14(10(2)18-9)17(21)25-4)11-7-5-6-8-12(11)19(22)23/h5-8,15,18H,1-4H3
InChi Key
HYIMSNHJOBLJNT-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    1 g

    $22

    Add

    5 g

    $42

    Add

    10 g

    $70

    Add
    Product Description

    Nifedipine is a dihydropyridine L-type calcium channel blocker that reduces the amplitude of spontaneous contractions in isolated rabbit ileum when used at a concentration of 1 μM.1 Nifedipine (1 μM) reduces TGF-β-induced calcium oscillations in human fibroblasts and prevents impairment of lung function in a mouse model of pulmonary fibrosis induced by bleomycin (Item No. 13877) when administered at a dose of 10 mg/kg per day.2 It also reduces increases in mean arterial blood pressure induced by angiotensin II (Item No. 17150) in spontaneously hypertensive rats when administered at a dose of 10 μg/kg.3 Formulations containing nifedipine have been used in the treatment of hypertension and angina.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Ragy, M., and Elbassuoni, E. The role of nitric oxide and L-type calcium channel blocker in the contractility of rabbit ileum in vitro. J. Physiol. Biochem. 68(4), 521-528 (2012).

    2. Mukherjee, S., Ayaub, E., Murphy, J., et al. Disruption of calcium signaling in fibroblasts and attenuation of bleomycin-induced fibrosis by nifedipine. Am. J. Respir. Cell Mol. Biol. 53(4), 450-458 (2015).

    3. Aritomi, S., Konda, T., and Yoshimura, M. L/N-type calcium channel blocker suppresses reflex aldosterone production induced by antihypertensive action. Heart Vessels 27(4), 419-423 (2012).